Chou Che-Yi, Liang Chih-Chia, Kuo Huey-Liang, Chang Chiz-Tzung, Liu Jiung-Hsiun, Lin Hsin-Hung, Wang I-Kuan, Yang Ya-Fei, Huang Chiu-Ching
Kidney Institute and Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan ; Department of Medicine, China Medical University, Taichung, Taiwan.
Kidney Institute and Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
PLoS One. 2014 Feb 4;9(2):e87891. doi: 10.1371/journal.pone.0087891. eCollection 2014.
Chronic kidney disease (CKD) patients are at risk for developing new-onset diabetes mellitus (NODM) even after hemodialysis (HD) and peritoneal dialysis (PD) treatment. It is not clear if the incidence for NODM is different in CKD patients receiving HD and PD. This study compared the risk of NODM in PD patients and HD patients.
All HD and PD patients in Taiwan Renal Registry Database from 1997 to 2005 were included and all patients were followed to December 31, 2008. The risk of NODM was analyzed in PD patients and propensity score matched HD patients using logistic regression for early type NODM (< = 6 months after dialysis) and Cox regression for late type NODM (>6 months after dialysis).
A total of 2548 PD patients and 10192 HD patients who had no diabetes on the initiation of dialysis were analyzed. The incidence for NODM was 3.7 per 100 patient/year for HD and 2.4 for PD patients. HD patients are more at risk for developing early type NODM (p<0.001) with an adjusted odds ratio of 1.41 [95% confidence interval (CI) 1.12-1.78)]. HD patients are more at risk for late type NODM (p<0.001) with an adjusted hazard ratio of 2.01 (95% CI: 1.77-2.29). Patient's age was negatively associated with risk of early type of NODM (p<0.001) but positively associated with risk of late type NODM (p<0.001).
Chronic kidney disease patients receiving hemodialysis are more at risk for developing new-onset diabetes mellitus compared to those receiving peritoneal dialysis.
慢性肾脏病(CKD)患者即使在接受血液透析(HD)和腹膜透析(PD)治疗后仍有发生新发糖尿病(NODM)的风险。目前尚不清楚接受HD和PD治疗的CKD患者中NODM的发病率是否存在差异。本研究比较了PD患者和HD患者发生NODM的风险。
纳入1997年至2005年台湾肾脏登记数据库中的所有HD和PD患者,并对所有患者随访至2008年12月31日。使用逻辑回归分析早期NODM(透析后≤6个月)的PD患者和倾向评分匹配的HD患者发生NODM的风险,使用Cox回归分析晚期NODM(透析后>6个月)的风险。
共分析了2548例开始透析时无糖尿病的PD患者和10192例HD患者。HD患者NODM的发病率为每100患者/年3.7例,PD患者为2.4例。HD患者发生早期NODM的风险更高(p<0.001),调整后的优势比为1.41[95%置信区间(CI)1.12-1.78]。HD患者发生晚期NODM的风险更高(p<0.001),调整后的风险比为2.01(95%CI:1.77-2.29)。患者年龄与早期NODM风险呈负相关(p<0.001),但与晚期NODM风险呈正相关(p<0.001)。
与接受腹膜透析的慢性肾脏病患者相比,接受血液透析的患者发生新发糖尿病的风险更高。